المؤلفون: Batgi H; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Başcı S; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Dal MS; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Kızıl Çakar M; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Uncu Ulu B; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Yiğenoğlu TN; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Özcan N; Department of Clinical Biochemistry, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Kılınç A; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Merdin A; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Yıldız J; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Bakırtaş M; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Şahin D; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Darçın T; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, İskender D; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Baysal NA; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey, Altuntaş F; Department of Hematology and Bone Marrow Transplantation Center, Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, University of Health Sciences, Ankara, Turkey

المصدر: Turkish journal of medical sciences [Turk J Med Sci] 2021 Apr 30; Vol. 51 (2), pp. 685-692. Date of Electronic Publication: 2021 Apr 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: Electronic Cited Medium: Internet ISSN: 1303-6165 (Electronic) Linking ISSN: 13000144 NLM ISO Abbreviation: Turk J Med Sci Subsets: MEDLINE

مواضيع طبية MeSH: Cisplatin/*therapeutic use , Deoxycytidine/*analogs & derivatives , Dexamethasone/*therapeutic use , Lymphoma/*drug therapy, Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Deoxycytidine/therapeutic use ; Female ; Hematopoietic Stem Cell Mobilization ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies ; Transplantation, Autologous ; Treatment Outcome ; Gemcitabine

المؤلفون: Erkurt MA; Department of Hematology, Inönü University Medical Faculty, Malatya, Turkey. Electronic address: erkurtali@hotmail.com., Berber I; Department of Hematology, Inönü University Medical Faculty, Malatya, Turkey., Tekgündüz E; Hematology and HCT Clinic, Ankara Oncology Hospital, Ankara, Turkey., Dogu MH; Department of Hematology, Pamukkale University Medical Faculty, Denizli, Turkey., Korkmaz S; Hematology Division, Kayseri Trainer and Research Hospital, Kayseri, Turkey., Demir C; Department of Hematology, Yüzüncü Yıl University Medical Faculty, Van, Turkey., Yilmaz M; Department of Hematology, Antep University Medical Faculty, Gaziantep, Turkey., Akay OM; Department of Hematology, Osmangazi University Medical Faculty, Eskişehir, Turkey., Pala C; Department of Hematology, Erciyes University Medical Faculty, Kayseri, Turkey., Bilen Y; Department of Hematology, Atatürk University Medical Faculty, Erzurum, Turkey., Kaya E; Department of Hematology, Inönü University Medical Faculty, Malatya, Turkey., Sari I; Department of Hematology, Pamukkale University Medical Faculty, Denizli, Turkey., Sencan M; Department of Hematology, Cumhuriyet University Medical Faculty, Sivas, Turkey., Kuku I; Department of Hematology, Inönü University Medical Faculty, Malatya, Turkey., Altuntaş F; Hematology and HCT Clinic, Ankara Oncology Hospital, Ankara, Turkey; Department of Internal Medicine, Division of Hematology, Yıldırım Beyazıt University Medical Faculty, Ankara, Turkey., Dal MS; Hematology and HCT Clinic, Ankara Oncology Hospital, Ankara, Turkey., Aydogdu I; Department of Hematology, Celal Bayar University Medical Faculty, Manisa, Turkey.

المصدر: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis [Transfus Apher Sci] 2016 Feb; Vol. 54 (1), pp. 80-4. Date of Electronic Publication: 2016 Jan 12.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Pergamon Country of Publication: England NLM ID: 101095653 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-0502 (Print) Linking ISSN: 14730502 NLM ISO Abbreviation: Transfus Apher Sci

مواضيع طبية MeSH: Practice Patterns, Physicians'* , Stem Cell Transplantation*, Central Nervous System Neoplasms/*therapy , Lymphoma/*therapy, Aged ; Aged, 80 and over ; Demography ; Humans ; Middle Aged ; Recurrence ; Retrospective Studies ; Transplantation, Autologous ; Young Adult

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Mert, Duygu, Dal, Mehmet Sinan, Duygu, Fazilet, Demirelli, Meryem, Ogan, Cihat, Batgi, Hikmetullah, Arat, Muret Ersöz, Onursever, Aykut, Tekgündüz, Emre

المصدر: Journal of Microbiology & Infectious Diseases; Sep2016, Vol. 6 Issue 3, p140-144, 5p

مصطلحات موضوعية: KILLER cells, NASAL cavity cancer

المؤلفون: Ismet Aydogdu, Zafer Gokgoz, Serdal Korkmaz, Mehmet Sinan Dal, Mehmet Yilmaz, Gulsum Akgun Cagliyan, Orhan Ayyildiz, Fevzi Altuntaş, Ali Kaya, Mehmet Şencan, Omur Gokmen Sevindik, Cengiz Demir, Bulent Eser, Yusuf Bilen, Alma Aslan, Aliihsan Gemici, Fahri Şahin, Mehmet Hilmi Dogu, Meltem Olga Akay, Hatice Terzi

المساهمون: [Gemici, Aliihsan] Sanliurfa Mehmet AkifInan Training & Res Hosp, Div Hematol, Sanliurfa, Turkey -- [Aydogdu, Ismet] Celal Bayar Univ, Dept Hematol, Manisa, Turkey -- [Terzi, Hatice -- Sencan, Mehmet] Cumhuriyet Univ, Dept Hematol, Sivas, Turkey -- [Aslan, Alma] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey -- [Kaya, Ali Hakan -- Dal, Mehmet Sinan -- Altuntas, Fevzi] Ankara Oncol Training & Res Hosp, Hematol & Stem Cell Transplantat Clin, Ankara, Turkey -- [Akay, Meltem Olga] Osmangazi Univ, Dept Hematol, Eskisehir, Turkey -- [Dogu, Mehmet Hilmi] Istanbul Training & Res Hosp, Div Hematol, Istanbul, Turkey -- [Ayyildiz, Orhan] Dicle Univ, Dept Hematol, Diyarbakir, Turkey -- [Sahin, Fahri] Ege Univ, Dept Hematol, Izmir, Turkey -- [Cagliyan, Gulsum Akgun] Denizli State Hosp, Div Hematol, Denizli, Turkey -- [Yilmaz, Mehmet] Gaziantep Univ, Dept Hematol, Gaziantep, Turkey -- [Gokgoz, Zafer] Ordu State Hosp, Div Hematol Ordu, Ordu, Turkey -- [Bilen, Yusuf] Ataturk Univ, Dept Hematol, Erzurum, Turkey -- [Demir, Cengiz] Yuzuncu Yil Univ, Dept Hematol, Van, Turkey -- [Sevindik, Omur Gokmen] Firat Univ, Dept Hematol, Elazig, Turkey -- [Korkmaz, Serdal] Kayseri Training & Res Hosp, Div Hematol, Kayseri, Turkey -- [Eser, Bulent] Erciyes Univ, Dept Hematol, Kayseri, Turkey, Altuntas, Fevzi -- 0000-0001-6872-3780, Division of Hematology, Sanliurfa Mehmet AkifInan Training and Research Hospital, Sanliurfa, Turkey, Department of Hematology, Celal Bayar University, Manisa, Turkey, Department of Hematology, Cumhuriyet University, Sivas, Turkey, Department of Medical Oncology, Hacettepe University, Ankara, Turkey, Hematology and Stem Cell Transplantation Clinic, Ankara Oncology Training and Research Hospital, Ankara, Turkey, Department of Hematology, Osmangazi University, Eskisehir, Turkey, Division of Hematology, Istanbul Training and Research Hospital, Istanbul, Turkey, Department of Hematology, Dicle University, Diyarbakir, Turkey, Department of Hematology, Ege University, Izmir, Turkey, Division of Hematology, Denizli State Hospital, Denizli, Turkey, Department of Hematology, Gaziantep University, Gaziantep, Turkey, Ordu State Hospital, Division of Hematology, Ordu, Turkey, Department of Hematology, Ataturk University, Erzurum, Turkey, Department of Hematology, YuzuncuYil University, Van, Turkey, Department of Hematology, Firat University, Elazig, Turkey, Division of Hematology, Kayseri Training and Research Hospital, Kayseri, Turkey, Department of Hematology, Erciyes University, Kayseri, Turkey

المصدر: Hematological Oncology. 36:116-120

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Adolescent, overall survival, Salvage therapy, Gastroenterology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Chemoimmunotherapy, Median follow-up, DHAP, Internal medicine, medicine, Humans, Progression-free survival, Aged, Retrospective Studies, treatment, business.industry, nodular lymphocyte predominant Hodgkin's lymphoma, Hematology, General Medicine, Middle Aged, medicine.disease, Hodgkin Disease, Nodular lymphocyte predominant Hodgkin's lymphoma, Lymphoma, Surgery, Oncology, 030220 oncology & carcinogenesis, Female, business, progression-free survival, Progressive disease, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49c71d25553dbbfc09d8c017965293c1
https://doi.org/10.1002/hon.2460

المؤلفون: Cigdem Pala, Mehmet Hilmi Dogu, Yusuf Bilen, Ismail Sari, Ismet Aydogdu, Cengiz Demir, Irfan Kuku, Ilhami Berber, Serdal Korkmaz, Mehmet Sinan Dal, Olga Meltem Akay, Emin Kaya, Mehmet Şencan, Fevzi Altuntaş, Mehmet Ali Erkurt, Emre Tekgündüz, Mehmet Yilmaz

المساهمون: [Erkurt, Mehmet Ali -- Berber, Ilhami -- Kaya, Emin -- Kuku, Irfan] Inonu Univ, Fac Med, Dept Hematol, TR-44069 Malatya, Turkey -- [Tekgunduz, Emre -- Altuntas, Fevzi -- Dal, Mehmet Sinan] Ankara Oncol Hosp, Hematol & HCT Clin, Ankara, Turkey -- [Dogu, Mehmet Hilmi -- Sari, Ismail] Pamukkale Univ, Fac Med, Dept Hematol, Denizli, Turkey -- [Korkmaz, Serdal] Kayseri Trainer & Res Hosp, Div Hematol, Kayseri, Turkey -- [Demir, Cengiz] Yuzuncu Yil Univ, Fac Med, Dept Hematol, Van, Turkey -- [Yilmaz, Mehmet] Antep Univ, Fac Med, Dept Hematol, Gaziantep, Turkey -- [Akay, Olga Meltem] Osmangazi Univ, Fac Med, Dept Hematol, Eskisehir, Turkey -- [Pala, Cigdem] Erciyes Univ, Fac Med, Dept Hematol, Kayseri, Turkey -- [Bilen, Yusuf] Ataturk Univ, Fac Med, Dept Hematol, Erzurum, Turkey -- [Sencan, Mehmet] Cumhuriyet Univ, Fac Med, Dept Hematol, Sivas, Turkey -- [Altuntas, Fevzi] Yildirim Beyazit Univ, Fac Med, Dept Internal Med, Div Hematol, Ankara, Turkey -- [Aydogdu, Ismet] Celal Bayar Univ, Fac Med, Dept Hematol, Manisa, Turkey, KAYA, Emin -- 0000-0001-8605-8497, Altuntas, Fevzi -- 0000-0001-6872-3780

مصطلحات موضوعية: demography, autologous stem cell transplantation, Lymphoma, recurrent disease, medicine.medical_treatment, retrospective study, very elderly, recurrence free survival, Autologous stem cell transplantation, Gastroenterology, etoposide, medical record review, Aged, Aged, 80 and over, Central Nervous System Neoplasms/*therapy, Demography, Humans, Lymphoma/*therapy, Middle Aged, Practice Patterns, Physicians', Recurrence, Retrospective Studies, Stem Cell Transplantation, Transplantation, Autologous, Young Adult, Central Nervous System Neoplasms, 0302 clinical medicine, Autologous stem-cell transplantation, cytarabine, middle aged, High-dose chemotherapy, Young adult, busulfan, general practice, relapse, CNS lymphoma, adult, Primary central nervous system lymphoma, clinical trial, Hematology, clinical practice, aged, female, 030220 oncology & carcinogenesis, young adult, medicine.drug, medicine.medical_specialty, thiotepa, overall survival, cancer prognosis, stem cell transplantation, Article, cancer chemotherapy, 03 medical and health sciences, remission, male, Internal medicine, medicine, cancer radiotherapy, follow up, human, PCNSL, Chemotherapy, autotransplantation, primary central nervous system lymphoma, business.industry, Retrospective cohort study, medicine.disease, major clinical study, mortality, Surgery, melphalan, Radiation therapy, Methotrexate, multicenter study, cyclophosphamide, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f9d187112f4061bff65ee36e823bff4
https://avesis.yyu.edu.tr/publication/details/0e02812a-f0d6-4f68-b448-158cff699d3a/oai